Standard
Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study. / Lund, A.; Baekdal, M.; Nielsen, S. W.; Hansen, C. P.; Storkholm, J. H.; Hartmann, B.; Holst, J. J.; Vilsbøll, T.; Knop, F. K.
I:
Diabetologia, Bind 63, Nr. Suppl. 1, 574, 2020, s. S276.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning
Harvard
Lund, A, Baekdal, M, Nielsen, SW, Hansen, CP, Storkholm, JH
, Hartmann, B, Holst, JJ, Vilsbøll, T & Knop, FK 2020, '
Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study',
Diabetologia, bind 63, nr. Suppl. 1, 574, s. S276. <
https://link.springer.com/article/10.1007/s00125-020-05221-5>
APA
Lund, A., Baekdal, M., Nielsen, S. W., Hansen, C. P., Storkholm, J. H.
, Hartmann, B., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2020).
Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study.
Diabetologia,
63(Suppl. 1), S276. [574].
https://link.springer.com/article/10.1007/s00125-020-05221-5Vancouver
Lund A, Baekdal M, Nielsen SW, Hansen CP, Storkholm JH, Hartmann B o.a. Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study. Diabetologia. 2020;63(Suppl. 1):S276. 574.
Author
Lund, A. ; Baekdal, M. ; Nielsen, S. W. ; Hansen, C. P. ; Storkholm, J. H. ; Hartmann, B. ; Holst, J. J. ; Vilsbøll, T. ; Knop, F. K. / Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study. I: Diabetologia. 2020 ; Bind 63, Nr. Suppl. 1. s. S276.
Bibtex
@article{551130db2e774d8ab10ded2ed47fb50e,
title = "Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study",
author = "A. Lund and M. Baekdal and Nielsen, {S. W.} and Hansen, {C. P.} and Storkholm, {J. H.} and B. Hartmann and Holst, {J. J.} and T. Vilsb{\o}ll and Knop, {F. K.}",
year = "2020",
language = "English",
volume = "63",
pages = "S276",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "Suppl. 1",
note = "56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) ; Conference date: 21-09-2020 Through 25-09-2020",
}
RIS
TY - ABST
T1 - Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study
AU - Lund, A.
AU - Baekdal, M.
AU - Nielsen, S. W.
AU - Hansen, C. P.
AU - Storkholm, J. H.
AU - Hartmann, B.
AU - Holst, J. J.
AU - Vilsbøll, T.
AU - Knop, F. K.
PY - 2020
Y1 - 2020
M3 - Conference abstract in journal
VL - 63
SP - S276
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - Suppl. 1
M1 - 574
T2 - 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
Y2 - 21 September 2020 through 25 September 2020
ER -
